期刊文献+

阿帕替尼联合鸦胆子注射液治疗晚期恶性肿瘤的临床研究 被引量:2

Clinical study of apatinib combined with brucea javanica injection in the treatment of advanced malignant tumors
下载PDF
导出
摘要 目的观察阿帕替尼联合鸦胆子注射液治疗晚期恶性肿瘤的临床疗效。方法选取符合诊断标准的晚期恶性肿瘤患者30例。对照组单用阿帕替尼,治疗组在对照组基础上加用鸦胆子注射液,用CHOI标准评价疗效,用KPS评分评价生活质量。结果治疗组疾病控制率(70.59%)高于对照组疾病控制率(38.46%),治疗组PFS(6.25月)长于对照组PFS(5.46月)(P<0.05)。结论鸦胆子注射液联合阿帕替尼治疗晚期恶性肿瘤能延长患者的生存时间,改善生活质量。 Objective To observe the clinical efficacy of apatinib combined with brucea javanica injection in the treatment of advanced malignant tumors.Methods 30 patients with advanced malignant tumors who met the diagnostic criteria were selected.The control group was treated with apatinib alone,and the treatment group was treated with brucea javanica injection on the basis of the control group.The efficacy was evaluated by CHOI standard.KPS score was used to evaluate the quality of life.Results The disease control rate of the treatment group was 70.59%,higher than that of the control group(38.46%);the PFS of the treatment group(6.25 months)was longer than that of the control group(5.46 months)(P<0.05).Conclusion Brucea javanica injection combined with apatinib in the treatment of advanced malignant tumors can prolong the survival time of patients,improve the quality of life.
作者 段轶茜 Duan Yiqian(Department of Oncology,Nantong Third People's Hospital,Nantong 226005,China)
出处 《国际医药卫生导报》 2019年第22期3747-3749,共3页 International Medicine and Health Guidance News
关键词 鸦胆子 阿帕替尼 恶性肿瘤 Brucea javanica Apatinib Malignant tumors
  • 相关文献

参考文献14

二级参考文献142

  • 1刘淑英,王晓稼.贝伐单抗在肿瘤治疗中相关毒副反应[J].肿瘤学杂志,2009,15(12):1133-1135. 被引量:3
  • 2胡大一,刘梅林,郭艺芳.老年高血压的诊断与治疗中国专家共识(2011版)[J].中国医学前沿杂志(电子版),2012,4(2):31-39. 被引量:101
  • 3杨学宁,吴一龙.实体瘤治疗疗效评价标准——RECIST[J].循证医学,2004,4(2):85-90. 被引量:1480
  • 4Ramon Andrade de Mello,Andrea Marin Marques,António Araújo.HER2 therapies and gastric cancer:A step forward[J].World Journal of Gastroenterology,2013,19(37):6165-6169. 被引量:7
  • 5Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015, 65(2):87-108.
  • 6World Health Organization. Health statistics and information sys- tems: WHO mortality database [ EB/OL 1- 2014 [ 2015-08-10 ]. http ://who. int/healthinfo/mortality_data./en/.
  • 7中国肿瘤登记中心.2015年中国肿瘤登记年报[EB/OL].2015[2015—08-10].http://www.huaxia.com/sp/xwss/dlxw/2015/04/4355225.html.
  • 8国家卫生部.胃癌诊疗规范(2011年版)[EB/OL].2011-02-16[2015-08-10].http://www.nhfpc.gov.cn/yzygj/s3585u/201103/96ce9016858d416f83da688df45e3f2e.shtml.
  • 9Li J, Qin S, Xu J, et al. Apatinib for chemotherapy-refractory advanced metastatic gastric cancer: results from a randomized, placebo-controlled, parallel-arm, phase II trial [ J ]. J Clin Oncol, 2013, 31(26):3219-3225.
  • 10Qin SK. Phase llI study of Apatinib in advanced gastric cancer: A randomized, double-blind, placebo-controlled trial[ C ]. J Clin Oncol, 2014, 32( 15 Suppl) : a4003.

共引文献619

同被引文献22

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部